Articles from Advances in Gastrointestinal Cancer (September 1, 2008)

Title	Author	Type	Words
A randomized Phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.	Gullen-Ponce, Carmen; Carrato, Alfredo	Report	762
A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.	Labianca, Roberto	Clinical report	494
Annual meeting of the American Society of Clinical Oncology (ASCO), 2008.	Kohne, Claus-Henning	Report	3615
Chemotherapy in advanced gastric cancer.	Bianchini, Diletta; Wong, Rachel	Report	4141
Perioperative management of gastro-oesophageal cancer.	Petkar, Imran; Okines, Alicia	Report	3716
Translational research in oesophagogastric cancer: still a long way to go to clinical application.	Grabsch, Heike	Report	6490
Treatment of gastro-oesophageal cancers: the need for international co-operation.	Wong, Rachel; Cunningham, David	Editorial	1016
Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.	Petkar, Imran; Cunningham, David	Report	1911